Clinical Development Of Biosimilars
This track includes Clinical trials on major diseases Risk management, and quality affairs, Case studies, and clinical models, Transgenic animals, Targeted cell line development, PK/PD studies, Toxicological studies, ethics maintained in clinical and preclinical studies, development difficulties and Aspects of genotoxicity tests. Biosimilar guidelines on the above mentioned topics are also to be thrown light upon at this biosimilars conference.
Â
Â
- Biosimilars Clinical Trials
- Toxicological studies
- Clinical PK/PD studies
- Targeted cell line development
- Transgenic animals
- Case studies, and clinical models
- Clinical trials on major diseases
- Biosimilars Clinical Studies
- Aspects of genotoxicity tests
- Case studies and clinical models
- Biologics Product Life Cycle and Sustainable Market Returns
Related Conference of Clinical Development Of Biosimilars
Clinical Development Of Biosimilars Conference Speakers
Recommended Sessions
- Bioequivalence Assessment
- Biologics and Biosimilars
- Biopharmaceuticals
- Biosimilars & Biologics: Clinical Studies & Trials
- Biosimilars & Biologics: Current Challenges
- Biosimilars Analytical Strategies
- Biosimilars: Pharmacovigilance and Safety
- Challenges in Biosimilars Pharmacovigilance
- Clinical Development Of Biosimilars
- Globalization of Biosimilars
- Innovation and Technology for Biosimilar Development
- Pharmaceutical Regulatory Affairs And IPR
- Regulatory Approach for Biosimilars
- Therapeutic Biological Products